Prevention of prostate cancer through custom tailoring of chemopreventive regimen.

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Abstract Text:

Imtiaz A Siddiqui,Farrukh Afaq,Vaqar M Adhami,Hasan Mukhtar,

One practical way to control cancer is through chemoprevention, which refers to the administration of synthetic or naturally occurring agents to block, reverse or delay the process of carcinogenesis. For a variety of reasons, the most important of which is human acceptance, for chemopreventive intervention naturally occurring diet-based agents are preferred over synthetic agents. For a long time, the prevailing mantra of cancer chemoprevention has been: "Find effective agents with acceptable or no toxicity and use them in preventing cancer in relatively healthy people or individuals at high risk for developing cancer". In pursuing this goal many naturally occurring phytochemicals capable of affording protection against carcinogenesis in preclinical settings in experimental animals have been described. However, clinical trials of single agents have yielded disappointing results. Since carcinogenesis is a multistage phenomenon in which many normal cellular pathways become aberrant, it is unlikely that one agent could prove effective in preventing cancer. This review underscores the need to build an armamentarium of naturally occurring chemopreventive substances that could prevent or slow down the development and progression of prostate cancer. Thus, the new effective approach for cancer prevention "building a customized mechanism-based chemoprevention cocktail of naturally occurring substances" is advocated.

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Publishing Authors By Initials

IA Siddiqui,F Afaq,VM Adhami,H Mukhtar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Chemico-biological interactions

VOLUME: 171

Page Numbers: 122-32

Journal Abbreviation: Chem. Biol. Interact.

ISSN: 0009-2797

DAY: 12

MONTH: 03

YEAR: 2007

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 227276

Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Prevention of prostate cancer through custom tailoring of chemopreventive regimen. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Prevention of prostate cancer through custom tailoring of chemopreventive regimen.

AFFILIATION: Department of Dermatology, University of Wisconsin, Madison, WI 53706, United States.

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Chem Biol Interact

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Prevention of prostate cancer through custom tailoring of chemopreventive regimen Related Publications

• A novel antioxidant 3-O-Caffeoyl-1-methylquinic acid enhances ultraviolet A-mediated apoptosis in immortalized HaCaT keratinocytes via Sp1-dependent transcriptional activation of p21(WAF1/Cip1).
• Apoptosis by dietary factors: the suicide solution for delaying cancer growth.
• Cancer chemoprevention through dietary antioxidants: progress and promise.
• Cannabinoids for cancer treatment: progress and promise.
• Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise.
• Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro.
• Complete genome analysis of a highly pathogenic H5N1 influenza A virus isolated from a tiger in China.
• Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
• Demographic and clinical features of diabetes mellitus in 1095 Yemeni patients.
• Dietary agents for chemoprevention of prostate cancer.
• Effects of highly active antiretroviral therapy on HIV-1-associated oral complications.
• Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells.
• Green tea and skin.
• Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
• Identification of Leishmania donovani as a cause of cutaneous leishmaniasis in Sudan.
• Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx.
• Inhibition of epidermal growth factor receptor signaling pathway by delphinidin, an anthocyanidin in pigmented fruits and vegetables.
• Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
• Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis.
• MP 48 expression in red blood cells of renal transplant recipients.
• MP84 expression in the urine specimens of acute rejection renal transplant recipients.
• Neuroscience of HIV Infection - Eighth International Meeting. Basic Research and Clinical Frontiers.
• Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
• Pomegranate derived products for cancer chemoprevention.
• Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice.
• Prescribing for asthmatic children in primary care. Are we following guidelines?
• Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
• Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
• Tea beverage in chemoprevention and chemotherapy of prostate cancer.
• Unusual clinical presentation of a severely protruding premaxilla in patient with bilateral clefts.